Huyghe J P, Verbraeken H, Goes F, De Wilde G, Hanssens M, Brabant P, Van Hijfte R, De Laey J J
Department of Ophthalmology, State University Ghent, University Hospital, Belgium.
Bull Soc Belge Ophtalmol. 1990;238:137-43.
Fourty patients with a malignant melanoma of the choroid were treated with ruthenium applicators. Depending on the height of the tumour, the patients were divided into 3 groups. In the first group with a tumour height superior to 6 mm the results were poor as well from a functional point of view as considering tumour regression. In a second group with a tumour height between 5 and 6 mm the results were favourable concerning tumour regression, but only in 50% of the cases did the eye remain functional. The results in the third group with a tumour height between 2 and 5 mm were satisfactory. Tumour regression was obtained in 96% of the eyes; 86% of the eyes remained functional. Tumour related death (7.5%) was not correlated with initial height of the tumour at the time of diagnosis.
40例脉络膜恶性黑色素瘤患者接受了钌敷贴器治疗。根据肿瘤高度，将患者分为3组。在第一组中，肿瘤高度超过6mm，从功能角度以及肿瘤消退情况来看，结果都很差。在第二组中，肿瘤高度在5至6mm之间，肿瘤消退情况良好，但仅50%的病例眼睛仍保持功能。在第三组中，肿瘤高度在2至5mm之间，结果令人满意。96%的眼睛实现了肿瘤消退；86%的眼睛仍保持功能。肿瘤相关死亡（7.5%）与诊断时肿瘤的初始高度无关。
